WO1998045435A3 - Secreted expressed sequence tags (sests) - Google Patents

Secreted expressed sequence tags (sests) Download PDF

Info

Publication number
WO1998045435A3
WO1998045435A3 PCT/US1998/006954 US9806954W WO9845435A3 WO 1998045435 A3 WO1998045435 A3 WO 1998045435A3 US 9806954 W US9806954 W US 9806954W WO 9845435 A3 WO9845435 A3 WO 9845435A3
Authority
WO
WIPO (PCT)
Prior art keywords
sests
sequence tags
expressed sequence
secreted expressed
secreted
Prior art date
Application number
PCT/US1998/006954
Other languages
French (fr)
Other versions
WO1998045435A2 (en
Inventor
Kenneth Jacobs
John M Mccoy
Edward R Lavallie
Lisa A Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J Agostino
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to JP54306898A priority Critical patent/JP2001519666A/en
Priority to EP98915360A priority patent/EP0973898A2/en
Priority to AU69566/98A priority patent/AU6956698A/en
Publication of WO1998045435A2 publication Critical patent/WO1998045435A2/en
Publication of WO1998045435A3 publication Critical patent/WO1998045435A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

Secreted expressed sequence tags (sESTs) isolated from a variety of human tissue sources are provided.
PCT/US1998/006954 1997-04-10 1998-04-10 SECRETED EXPRESSED SEQUENCE TAGS (sESTs) WO1998045435A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP54306898A JP2001519666A (en) 1997-04-10 1998-04-10 Secretory expression sequence tags (sESTs)
EP98915360A EP0973898A2 (en) 1997-04-10 1998-04-10 SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
AU69566/98A AU6956698A (en) 1997-04-10 1998-04-10 Secreted expressed sequence tags (sests)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83591397A 1997-04-10 1997-04-10
US08/835,913 1997-04-10

Publications (2)

Publication Number Publication Date
WO1998045435A2 WO1998045435A2 (en) 1998-10-15
WO1998045435A3 true WO1998045435A3 (en) 1998-11-12

Family

ID=25270781

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/006954 WO1998045435A2 (en) 1997-04-10 1998-04-10 SECRETED EXPRESSED SEQUENCE TAGS (sESTs)

Country Status (4)

Country Link
EP (1) EP0973898A2 (en)
JP (1) JP2001519666A (en)
AU (1) AU6956698A (en)
WO (1) WO1998045435A2 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312921B1 (en) 1996-07-26 2001-11-06 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
IL131560A0 (en) 1997-02-25 2001-01-28 Corixa Corp Compounds for immunotherapy of prostate cancer and methods for their use
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
AU7807298A (en) * 1997-06-04 1998-12-21 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
EP1627886A1 (en) * 1997-10-07 2006-02-22 Ono Pharmaceutical Co., Ltd. Polypeptide, cDNA encoding the same, and use of them
AU2493699A (en) * 1998-02-04 1999-08-23 Zymogenetics Inc. Angiopoietin homolog zapo3, dna encoding it, and method of making it
US6610526B2 (en) * 1998-03-13 2003-08-26 Inctye Corporation Human E1-like protein
US6277568B1 (en) 1998-04-09 2001-08-21 Incyte Genomics, Inc. Nucleic acids encoding human ubiquitin-conjugating enzyme homologs
AU4189999A (en) * 1998-05-18 1999-12-06 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
JP2002522016A (en) * 1998-07-22 2002-07-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Protein similar to neuroendocrine-specific protein and cDNA encoding the same
WO2000008056A1 (en) * 1998-08-07 2000-02-17 Ono Pharmaceutical Co., Ltd. NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
WO2000009693A2 (en) * 1998-08-11 2000-02-24 Darwin Discovery Ltd. Identification of the gene causing the mouse scurfy phenotype and its human ortholog
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000032746A2 (en) * 1998-11-30 2000-06-08 Millennium Pharmaceuticals, Inc. Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
EP1171589A1 (en) * 1999-04-15 2002-01-16 Cambridge University Technical Services Limited A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
GB9909161D0 (en) * 1999-04-21 1999-06-16 Smithkline Beecham Plc Novel compounds
EP1183370A2 (en) * 1999-05-20 2002-03-06 Incyte Genomics, Inc. Human oxidoreductase proteins
EP1180147A1 (en) * 1999-05-28 2002-02-20 ZymoGenetics, Inc. Secreted alpha-helical protein-31
EP1130094A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Primers for synthesizing full length cDNA clones and their use
AU5887700A (en) * 1999-10-19 2001-04-30 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
EP1226242A1 (en) * 1999-10-19 2002-07-31 Lexicon Genetics Incorporated Human cub-domain-containing protein and gene encoding the same
EP1616879A3 (en) * 1999-10-19 2006-11-29 Lexicon Genetics Incorporated Human cub-domain-containing protein and gene encoding the same
FR2800750B1 (en) 1999-11-05 2003-01-31 Centre Nat Rech Scient MEMBRANE PROTEINS CTL (CHOLINE TRANSPORTER LIKE) INVOLVED IN THE TRANSPORT OF CHOLINE
CA2398251A1 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
AU3797301A (en) 2000-01-26 2001-08-07 Urogenesys Inc 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
CA2395295A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins and antibodies
US7534417B2 (en) 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
AU4174201A (en) * 2000-02-24 2001-09-03 Urogenesys Inc 103p2d6: tissue specific protein highly expressed in various cancers
JP2004527210A (en) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー Evaluation method of endothelial cell expression pattern
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2002044357A2 (en) 2000-11-30 2002-06-06 Millennium Pharmaceuticals, Inc. Methods of using 18903 to treat pain and pain-related disorders
US20040115682A1 (en) * 2001-02-15 2004-06-17 Yusuke Nakamura Novel scavenger receptor class a protein
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
CN101443357A (en) 2005-08-12 2009-05-27 先灵公司 MCP1 fusions
AU2009211340B2 (en) 2008-02-04 2013-09-12 Lay Line Genomics S.P.A. Anti-TrkA antibodies and derivatives thereof
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014432A1 (en) * 1989-05-23 1990-11-29 Genetics Institute, Inc. A human cytokine, interleukin-9
WO1996017925A1 (en) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designated lerk-7
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997004097A2 (en) * 1995-07-19 1997-02-06 Genetics Institute, Inc. Human ctla-8 and uses of ctla-8-related proteins
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014432A1 (en) * 1989-05-23 1990-11-29 Genetics Institute, Inc. A human cytokine, interleukin-9
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1996017925A1 (en) * 1994-12-06 1996-06-13 Immunex Corporation Cytokine designated lerk-7
WO1997004097A2 (en) * 1995-07-19 1997-02-06 Genetics Institute, Inc. Human ctla-8 and uses of ctla-8-related proteins
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADAMS M D ET AL: "3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN", NATURE GENETICS, vol. 4, no. 3, July 1993 (1993-07-01), pages 256 - 267, XP000611495 *
JACOBS K ET AL: "A NOVEL METHOD FOR ISOLATING EUKARYOTIC CDNA CLONES ENCODING SECRETED PROTEINS", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, vol. 21A, 10 March 1995 (1995-03-10), pages 19, XP002027246 *

Also Published As

Publication number Publication date
WO1998045435A2 (en) 1998-10-15
JP2001519666A (en) 2001-10-23
AU6956698A (en) 1998-10-30
EP0973898A2 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
WO1998045435A3 (en) Secreted expressed sequence tags (sests)
WO1998045436A3 (en) Secreted expressed sequence tags (sests)
WO1998045437A3 (en) Secreted expressed sequence tags (sests)
AU2730195A (en) Walking aid
AU6790998A (en) Suture-passing forceps
AU5872696A (en) Endoscope
AU6030398A (en) Human proteins
AU1208200A (en) Secreted expressed sequence tags (sests)
AU8156598A (en) New human cathepsin
AU1208100A (en) Secreted expressed sequence tags (sests)
AU5904798A (en) Novel human metallothionein
AU6778296A (en) Anastomosis cuff
AU6579898A (en) Human pancreatitis-associated protein, pap-2
AU9303498A (en) Human aminopeptidase p gene
AU9017598A (en) Human frezzled-like protein
AU7954298A (en) Human protein phosphatase ii-c-like protein
AU5707498A (en) Novel human membrane protein
AU1702499A (en) Recognition e-circuits capable of translation-tolerant recognition
WO1997039123A3 (en) Secreted proteins
AU8155898A (en) Human preprotachykinin b
AU1645599A (en) Human matrilin-3
AU4744997A (en) Novel human phospholemman-like protein
AU6050198A (en) Novel human cystatin-like protein
AU5532496A (en) Human cystatin f
AU9376598A (en) Human (act)va-orf4-like protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 543068

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998915360

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998915360

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998915360

Country of ref document: EP